Journal articleJ Gastrointest Oncol2021
Mitofusin-2 is a novel anti-angiogenic factor in pancreatic cancer.
- Journal
- J Gastrointest Oncol
- Published
- 1 April 2021
- Citations
- 18
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Background Aberrant expression of mitofusin-2 (MFN2) has been found to be associated with vascular endothelial growth factor A (VEGFA)-mediated angiogenesis in human umbilical vein endothelial cells (HUVECs). This study aimed to investigate the expression of MFN2 in pancreatic cancer (PC) and the role of MFN2 in vascular endothelial cell growth and angiogenesis. … Excerpt only: this text is the publisher’s. Read it in full at the source.